MFN2 and diabetic cardiomyopathy: In previous literature, MFN2−/− mice spontaneously developed dilated cardiomyopathy with mitochondrial dysfunction and hyperfragmentation and targeting MFN2 effectively alleviated imbalanced dynamics as well as diabetic cardiomyopathy in obese diabetic mice.37, 38